Finding the right support is critical for anyone dealing with medication-induced injury. This page compiles professional services, medical specialists, peer support communities, and educational resources to help you navigate withdrawal, recovery, and healing.
Tapering & Deprescribing Services
To learn more about hyperbolic tapering and when tapering is and isn't appropriate, see our FAQ on tapering and withdrawal.
Finding physicians who understand protracted withdrawal and medication-induced injury can be challenging. When searching, look for practitioners who explicitly practice deprescribing and who understand hyperbolic tapering based on receptor occupancy principles. Many deprescribing practitioners still use linear dose reductions, which are inadequate at lower doses. Ask specifically whether they taper using progressively smaller absolute reductions, use liquid formulations or compounding pharmacies for low-dose precision, and understand the Horowitz & Taylor research on receptor occupancy-guided tapering.
TaperClinic
Website: taperclinic.com
Format: Fully virtual outpatient clinic (nationwide US coverage)
The only fully virtual outpatient clinic dedicated exclusively to tapering psychiatric medications. TaperClinic uses hyperbolic tapering with 5-10% dose reductions from the current dose every 2-4 weeks, slowing the rate toward the end — consistent with receptor occupancy principles. They taper benzodiazepines, SSRIs, SNRIs, TCAs, mood stabilizers, and antipsychotics. Includes weekly clinician-led group check-ins and an in-house advisory team for sleep, nutrition, and psychological support.
Outro Health
Website: outro.com
Format: Virtual clinic (select US states, expanding)
Co-founded by Dr. Mark Horowitz — the researcher whose work on receptor occupancy (Horowitz & Taylor, Lancet Psychiatry, 2019) established the scientific basis for hyperbolic tapering. Outro provides clinician-guided antidepressant tapering using the hyperbolic method, with custom compounded doses for the tiny reductions needed at lower doses. Monthly clinician visits with support between appointments. Currently focused on antidepressants (SSRIs, SNRIs), with plans to expand to benzodiazepines and gabapentinoids.
Educational Resources & Communities
Reliable sources of information, peer support communities, and advocacy organizations for medication safety, withdrawal, and informed consent.
Inner Compass Initiative / The Withdrawal Project
Website: thewithdrawn.org / innercompassinitiative.org
Peer-led resources on psychiatric medication withdrawal, including documentation tools, tapering guidance, support networks, and educational materials grounded in lived experience.
Mad in America
Website: madinamerica.com
Leading news and research site covering critical psychiatry, medication safety, and patient experiences. Features investigative journalism, scientific analysis, personal narratives, and a blog with in-depth coverage of psychiatric medication effects and withdrawal.
RxISK
Website: rxisk.org
Free, independent drug safety resource allowing patients to report adverse events and search adverse effect experiences. Founded by Dr. David Healy (psychiatrist and pharmacologist), it includes extensive blog analysis of drug safety issues, medication adverse effects, withdrawal syndromes, and regulatory failures.
BenzoBuddies
Website: benzobuddies.org
The largest and longest-running peer support forum dedicated to benzodiazepine withdrawal. Members share tapering experiences, withdrawal symptom management, recovery strategies, and emotional support. Includes extensive information archives and a vibrant community of thousands.
Surviving Antidepressants
Website: survivingantidepressants.org
Comprehensive peer support community and resource site focused on antidepressant withdrawal and protracted withdrawal syndrome. Includes detailed tapering protocols, withdrawal symptom information, and community forums.
Benzodiazepine Information Coalition
Website: benzoinfo.com
Comprehensive, factual information about benzodiazepine pharmacology, dependence, withdrawal, and tapering. Extensive educational materials on benzodiazepine safety and management.
PSSD Network
Website: pssdnetwork.org
Dedicated to research, support, and awareness of Post-SSRI Sexual Dysfunction (PSSD). Includes research findings, patient experiences, and advocacy for better recognition and treatment.
Moral Medicine
Website: moralmedicine.org
Patient advocacy organization raising awareness of severe, lasting side effects from commonly prescribed medications including finasteride, SSRIs, and Accutane. Funds research, amplifies patient testimonies, and advocates for treatments for conditions like Post-Finasteride Syndrome and Post-SSRI Sexual Dysfunction.
Taper Community
Website: taper.community
Peer support platform for safely reducing psychiatric medications through community guidance and evidence-based resources. Features drug-specific forums, shareable taper journals, and a directory of tapering-friendly clinicians.
SSRI Stories
Website: ssristories.net
An archive of over 5,000 documented cases of violence, suicide, and severe adverse behavioral events associated with psychiatric medications — primarily SSRIs and SNRIs. Each entry is sourced from news reports, court cases, FDA records, and published accounts. The sheer volume of documented incidents makes this one of the most comprehensive records of psychiatric medication-associated harm in existence.
Antidepressant Info
Website: antidepressantinfo.org
Community organization offering weekly support meetings for people affected by antidepressant withdrawal. Provides a regular, structured space to connect with others navigating withdrawal symptoms, tapering challenges, and recovery — particularly valuable for those who feel isolated or unsupported by their medical providers.
PFS Foundation
Website: pfsfoundation.org
Supports patients experiencing persistent adverse effects from finasteride (Propecia) and funds research into the mechanisms and treatments of Post-Finasteride Syndrome. Includes patient experiences, research updates, and advocacy.
Fluoroquinolone Toxicity Study
Website: fq100.org
Research and community resource for people experiencing adverse effects from fluoroquinolone antibiotics. Includes research findings, symptom documentation, and peer support for those dealing with FQAD.
Alliance for Benzodiazepine Best Practices
Website: benzoreform.org
Advocacy and education organization focused on promoting safer benzodiazepine prescribing and awareness of withdrawal risks. Includes clinical guidelines and patient education materials.
Psychiatric Medication Awareness Group
Website: psychmedaware.org
Educational organization providing resources about psychiatric medication adverse effects, withdrawal, and informed consent in psychiatric treatment.
Meta Groups
Peer-run support communities on Meta provide accessible, real-time peer support. These are lay-run groups where people share experiences and provide mutual encouragement.
- Benzo Warrior Community (BWC) — Large community for benzodiazepine withdrawal and recovery
- Benzodiazepine Withdrawal Support Group — Peer support for those tapering benzodiazepines
- Healing from Psych Drugs — General psychiatric medication withdrawal and recovery
- Fluoroquinolone Toxicity Syndrome Network — Support for fluoroquinolone antibiotic adverse effects
- PSSD Worldwide Support — Dedicated to Post-SSRI Sexual Dysfunction support
- PFS Foundation Community — Community support for Post-Finasteride Syndrome sufferers
- Accutane Long-Term Side Effects — Support community for those dealing with post-Accutane adverse effects
Note: Meta groups are peer-run communities. Quality, moderation, and accuracy vary. Use them for emotional support and shared experiences, but verify medical information with reliable sources and healthcare providers.
Dietary Interventions for Neurological Injury
A growing number of patients report significant improvement in neurological symptoms with strict ketogenic or carnivore diet adherence. While clinical trials specific to medication-induced injury are limited, the neuroprotective mechanisms of ketosis — reduced neuroinflammation, stabilized neuronal excitability, enhanced mitochondrial function, and reduced glutamate excitotoxicity — are well established and directly relevant to the neurological damage caused by psychiatric medications.
Metabolic Mind
Website: metabolicmind.org
A nonprofit initiative advancing metabolic psychiatry — the use of ketogenic and metabolic therapies for mental health and neurological conditions. Metabolic Mind funds research, provides educational resources for patients and clinicians, and maintains a growing evidence base on ketogenic interventions for brain-based conditions. Their peers and families section is a particularly useful starting point for patients exploring dietary approaches to neurological recovery.
The Lion Diet
Website: liondiet.com
An elimination-based carnivore protocol — eating exclusively ruminant meat, salt, and water — designed to identify and remove dietary triggers of inflammation and immune reactivity. Some patients with medication-induced neurological injury report that this strict elimination approach is more effective than standard ketogenic diets, potentially because it removes all plant-based compounds that could trigger immune or inflammatory responses in a sensitized nervous system. The site provides practical guidance on implementation, troubleshooting, and food reintroduction.
Note: Dietary interventions require strict adherence to see results — partial compliance typically does not produce meaningful benefit. Most patients who report improvement needed several weeks of strict adherence before noticing changes. Diet is not a cure, but for those it helps, it can meaningfully reduce the severity of symptoms. See our FAQ for more information.
Essential Books
Published works providing evidence-based analysis of psychiatric medication safety and informed consent:
Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America
Author: Robert Whitaker
A groundbreaking investigation into how psychiatric medications work, their long-term effects, and the epidemiological data showing rising rates of psychiatric disability in medicated populations. Essential reading for understanding the broader context of medication-induced harm.
Medication Madness: The Role of Psychiatric Drugs in Cases of Violence, Suicide and Crime
Author: Peter Breggin, M.D.
Dr. Breggin examines the capacity of psychiatric medications to cause violent and impulsive behavior, withdrawal syndromes, and other serious adverse effects. Includes case studies and analysis of medication-induced injuries.
Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare
Author: Peter Gøtzsche, M.D.
A critical examination of pharmaceutical industry practices, conflicts of interest in drug approval and marketing, and the gap between industry-sponsored research and independent evidence. Provides context for understanding why medication harms are underrecognized.
The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs
Authors: Mark Horowitz, M.D., Ph.D. & David Taylor, Ph.D.
The first major clinical guideline to incorporate hyperbolic tapering principles into deprescribing protocols. Based on receptor occupancy pharmacology, it provides evidence-based schedules for gradually reducing psychiatric medications — directly challenging the rapid tapers still standard in most clinical settings. Essential for patients and clinicians seeking safe discontinuation strategies.
Brain Energy: A Revolutionary Breakthrough in Understanding Mental Health — and Improving Treatment for Anxiety, Depression, OCD, PTSD, and More
Author: Christopher M. Palmer, M.D.
A Harvard psychiatrist presents the theory that mental disorders are metabolic disorders of the brain. Palmer synthesizes decades of research linking mitochondrial dysfunction to psychiatric conditions and makes the case for metabolic interventions — including the ketogenic diet — as treatments for mental illness. Directly relevant to understanding why dietary approaches may help with medication-induced neurological injury.
Let Them Eat Prozac: The Unhealthy Relationship Between the Pharmaceutical Industry and Depression
Author: David Healy, M.D.
Healy — a psychopharmacologist and one of the earliest researchers to document SSRI-induced suicidality — exposes how clinical trial data was manipulated to conceal serious adverse effects of antidepressants. A foundational text for understanding how the pharmaceutical industry shaped the narrative around SSRI safety.
Shipwreck of the Singular: Healthcare's Castaways
Author: David Healy, M.D.
Healy's most recent work examines how modern healthcare systems abandon patients who fall outside standard treatment narratives — particularly those harmed by medications. He documents how individuals with drug-induced injuries become "castaways" in a system that cannot acknowledge their condition, making this perhaps the most directly relevant book for anyone navigating medication-induced harm.
Antidepressed: A Breakthrough Examination of Epidemic Antidepressant Harm and Dependence
Author: Beverley Thomson
A comprehensive breakdown of the growing crisis of antidepressant harm and dependence — how we got here, what's happening to patients worldwide, and where we go from here. Covers the medicalization of mental health, the power of the informed patient, safe antidepressant management and withdrawal, and firsthand patient experiences.
May Cause Side Effects: A Memoir
Author: Brooke Siem
A memoir of antidepressant withdrawal from one of the first generation of minors prescribed antidepressants. After fifteen years and over 32,000 pills — initially prescribed in the wake of her father's sudden death — Siem chronicles the excruciating year of withdrawal and identity reconstruction that followed her decision to come off medication. Winner of the 2023 Best Indie Book Award for Memoir.
Unshrunk: A Story of Psychiatric Treatment Resistance
Author: Laura Delano
Equal parts memoir, history, and manifesto from the founder of Inner Compass Initiative. Delano chronicles her thirteen-year journey through psychiatric diagnoses, institutionalization, and a cascade of nineteen medications before tapering off and reclaiming her identity beyond diagnostic labels. A powerful exploration of what it means to resist a system that pathologizes normal human experience.
Reporting Adverse Drug Events
The adverse event reporting system is deeply flawed — FAERS captures an estimated 1-10% of adverse reactions that actually occur, and regulatory action is almost always too late. But it still matters. The fluoroquinolone black box warning and the EMA's recognition of PSSD both trace back to accumulated reports. The system is broken, but each report makes the evidence base harder to dismiss. Filing takes about 15 minutes and costs nothing.
United States (FDA)
FDA MedWatch Program
Online reporting, phone, or mail submissions.
- Website: fda.gov/medwatch
- Online Form: MedWatch Online
- Phone: 1-888-SAFEFDA (1-888-723-3332)
European Union (EMA)
EudraVigilance Platform
Reports processed through national competent authorities.
- Website: EMA Pharmacovigilance
- Patient Reporting: Contact your national medicines authority
United Kingdom (MHRA)
Yellow Card Scheme
Online, app, or paper reporting.
- Website: yellowcard.mhra.gov.uk
- Phone: 0800 731 6789
You Do Not Need Your Doctor's Permission
In most countries, patients can report adverse drug reactions directly to regulatory agencies. You do not need to go through your healthcare provider, and you do not need them to agree that the medication caused your symptoms. If your physician dismissed your experience, report it anyway. The report is yours to file.
These resources are provided for informational purposes. Inclusion on this page does not constitute endorsement of any organization or individual. The presence of a resource here means it may be helpful for people seeking support or information about medication-induced injury; it does not imply that all content is accurate or that we agree with every statement made by these organizations.
Always work with qualified medical professionals when making decisions about your medications. Peer support and educational resources are valuable complements to, but not substitutes for, professional medical care. If you are experiencing medication side effects or withdrawal symptoms, consult with your healthcare provider or seek a second opinion from another qualified physician.